These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15916041)

  • 1. The role of the Tat gene in the pathogenesis of HIV infection.
    Amarapal P; Tantivanich S; Balachandra K; Matsuo K; Pitisutithum P; Chongsa-nguan M
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):352-61. PubMed ID: 15916041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sequence analysis of human immunodeficiency virus type 1 tat gene among the long-term HIV infected non-progressoris in Yunnan province].
    Zhao F; Shao Y; Duan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):37-40. PubMed ID: 12759950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the relationship between the polymorphisms and secondary structure of tat exon-1 gene and HIV/ AIDS progress in subtype B' and B'/C].
    Han XX; Dai D; Zhang Y; Zhang M; Zhang ZN; Diao YY; Geng WQ; Shang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Nov; 27(11):968-72. PubMed ID: 17402200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.
    Li Y; Starr SE; Lisziewicz J; Ho WZ
    Gene Ther; 2000 Feb; 7(4):321-8. PubMed ID: 10694813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
    Noel RJ; Kumar A
    Virology; 2006 Mar; 346(1):127-38. PubMed ID: 16313937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
    Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently.
    Kashi VP; Jacob RA; Paul S; Nayak K; Satish B; Swaminathan S; Satish KS; Ranga U
    Vaccine; 2009 Nov; 27(48):6739-47. PubMed ID: 19744585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
    Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
    Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
    Buttò S; Fiorelli V; Tripiciano A; Ruiz-Alvarez MJ; Scoglio A; Ensoli F; Ciccozzi M; Collacchi B; Sabbatucci M; Cafaro A; Guzmán CA; Borsetti A; Caputo A; Vardas E; Colvin M; Lukwiya M; Rezza G; Ensoli B;
    J Infect Dis; 2003 Oct; 188(8):1171-80. PubMed ID: 14551888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and analysis of activity of an HIV-1/bovine immunodeficiency virus chimeric clone cDNA].
    Yang YS; Chen GM; Dong WP; Chen QM; Geng YQ; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):143-5. PubMed ID: 12869996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection.
    Rodriguez SK; Sarr AD; Olorunnipa O; Popper SJ; Gueye-Ndiaye A; Traoré I; Dia MC; Mboup S; Kanki PJ
    J Infect Dis; 2006 Sep; 194(6):760-3. PubMed ID: 16941341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
    Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
    Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
    AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection.
    Yim HC; Li JC; Lau JS; Lau AS
    AIDS; 2009 Jul; 23(12):1473-84. PubMed ID: 19622906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequence analysis of gag and env genes of HIV type 1 circulating in former blood donors of Fuyang city, Anhui province].
    Wang SH; Xing H; Wang JJ; Su B; Chen X; Quan Y; Zhao QB; Ruan YH; Xu JQ; Song YH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1535-9. PubMed ID: 17785105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles and pathway analysis in HEK 293 T cells overexpressing HIV-1 Tat and nucleocapsid using cDNA microarray.
    Park SE; Lee MJ; Yang MH; Ahn KY; Jang SI; Suh YJ; Myung H; You JC; Park JH
    J Microbiol Biotechnol; 2007 Jan; 17(1):154-61. PubMed ID: 18051367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
    Gupta S; Mitra D
    Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
    Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S
    Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.